Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petra Glander

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantationPetra Glander, Pia Hambach, Lutz Liefeldt, et al.
Journal of Women'S Health (2002)|November 1, 2017
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal TransplantationFriederike Bachmann, Petra Glander, Klemens Budde, et al.
Archives of Toxicology|August 24, 2012
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitroFlavia Schmidt, Kathrin Eckardt, Mehdi Shakibaei, et al.
Transplantation|March 15, 2006
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?Franca Fleiner, Lutz Fritsche, Petra Glander, et al.
Expert Opinion on Drug Safety|August 28, 2010
Enteric-coated mycophenolate sodiumKlemens Budde, Michael Dürr, Lutz Liefeldt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipientsMichael Duerr, Petra Glander, Fritz Diekmann, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 28, 2016
Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluationOlesja Rissling, Steffen Bauer, Maria Shipkova, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2010
Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantationMareen Matz, Marcel Naik, Mir-Farzin Mashreghi, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Therapeutic Drug Monitoring|May 1, 2010
Target enzyme activity as a biomarker for immunosuppressionPetra Glander, Klemens Budde
Annals of Transplantation|September 23, 2008
Pharmacokinetic principles of immunosuppressive drugsKlemens Budde, Petra Glander
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 6, 2011
Inosine 5'-monophosphate dehydrogenase activity as a biomarker in the field of transplantationPetra Glander, Pia Hambach, Lutz Liefeldt, et al.
Journal of Women'S Health (2002)|November 1, 2017
High Incidence of Ovarian Cysts in Women Receiving mTOR Inhibitors After Renal TransplantationFriederike Bachmann, Petra Glander, Klemens Budde, et al.
Archives of Toxicology|August 24, 2012
Effects of mycophenolic acid alone and in combination with its metabolite mycophenolic acid glucuronide on rat embryos in vitroFlavia Schmidt, Kathrin Eckardt, Mehdi Shakibaei, et al.
Transplantation|March 15, 2006
Reporting of rejection after renal transplantation in large immunosuppressive trials: biopsy-proven, clinical, presumed, or treated rejection?Franca Fleiner, Lutz Fritsche, Petra Glander, et al.
Expert Opinion on Drug Safety|August 28, 2010
Enteric-coated mycophenolate sodiumKlemens Budde, Michael Dürr, Lutz Liefeldt, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 23, 2010
Increased incidence of angioedema with ACE inhibitors in combination with mTOR inhibitors in kidney transplant recipientsMichael Duerr, Petra Glander, Fritz Diekmann, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 28, 2016
Simultaneous determination of mycophenolate and its metabolite mycophenolate-7-o-glucuronide with an isocratic HPLC-UV-based method in human plasma and stability evaluationOlesja Rissling, Steffen Bauer, Maria Shipkova, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 15, 2010
Evaluation of the novel protein kinase C inhibitor sotrastaurin as immunosuppressive therapy after renal transplantationMareen Matz, Marcel Naik, Mir-Farzin Mashreghi, et al.
Pageof 5